Bioequivalence and Bioavailability Forum

Adverse event or ADRs details vish14184 2008-10-13 10:55
- Adverse event or ADRs details Ohlbe 2008-10-13 18:03
- Adverse event or ADRs details debabrata 2008-10-14 10:30

Impartial Witness QA-Clinical 2008-10-04 08:44
- Impartial Witness H_Rotter 2008-10-04 12:30
  - Impartial Witness QA-Clinical 2008-10-08 08:26
    - Impartial Witness Ohlbe 2008-10-08 23:57
      - Impartial Witness QA-Clinical 2008-10-11 08:06

Scandinavia chiragkhatri 2008-10-08 07:50
- Scandinavia Helmut 2008-10-08 08:07
  - Scandinavia chiragkhatri 2008-10-10 07:21

Russian drug agency patel_prakash79 2008-10-06 12:54
- Russian drug agency Ohlbe 2008-10-06 14:40

Audit Trail M.Vasu 2008-10-03 07:51
- ICH E6 Helmut 2008-10-05 10:49

Meals sanilkumar 2008-10-04 10:34

certificate of analysis krishnamurthy ca 2008-10-01 06:36
- certificate of analysis Helmut 2008-10-01 10:45

narcotic drugs kaushal09 2008-09-29 11:26
- Handling of narcotic drugs Helmut 2008-09-29 12:46

Predose concentrations shri 2008-09-29 12:11
- Predose concentrations Jaime_R 2008-09-29 12:36

Terminology Maya 2008-09-17 11:23
- Terminology JPL 2008-09-19 16:36

random effect, fix effect in the guidance Appendix E LS 2008-02-05 18:53
- random effect, fix effect in the guidance Appendix E d_labes 2008-02-06 13:34
  - random effect, fix effect in the guidance Appendix E LS 2008-02-06 17:58
    - random effect, fix effect in the guidance Appendix E d_labes 2008-02-07 10:14
      - random effect, fix effect in the guidance Appendix E SKR 2008-03-06 10:54
        
        Satterthwaite degrees of freedom Helmut 2008-03-06 13:57
        
        Satterthwaite degrees of freedom d_labes 2008-03-10 09:59
        
        Satterthwaite DF; SAS Helmut 2008-03-10 12:24
        
        Satterthwaite DF; SAS d_labes 2008-03-10 14:50
        
        Satterthwaite DF; SAS mathews 2008-03-11 07:12
        
        SAS Proc Mixed coding, replicate design d_labes 2008-03-11 09:43
        
        SAS Proc Mixed coding, replicate design Sathya 2008-09-17 07:21
        
        Replicate design evaluation d_labes 2008-09-17 10:49
        
        Replicate design evaluation Sathya 2008-09-18 06:43

Minimum sample size (FDA) Maya 2008-09-17 10:13
- Minimum sample size (FDA) d_labes 2008-09-17 10:56
- Minimum sample size (FDA) Ohlbe 2008-09-17 11:14

Adverse Event Reporting such 2008-09-09 14:37
- Adverse Event Reporting Ohlbe 2008-09-09 17:14
  - Adverse Event Reporting such 2008-09-10 08:46
    - Adverse Event Reporting Ohlbe 2008-09-10 10:30
      - Adverse Event Reporting such 2008-09-10 11:42
        
        Adverse Event Reporting Ohlbe 2008-09-10 11:56

primary end point and secondary end point alinpharma 2008-09-09 14:05
- ICH E8 Ohlbe 2008-09-09 17:11
- ICH E9 martin 2008-09-09 21:48

Bioavailability Prediction shankar 2008-09-01 12:38
- Bioavailability Prediction shankar 2008-09-04 07:33

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
295 visitors (0 registered, 295 guests [including 17 identified bots]).
Forum time: 12:47 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz